Remdesivir Intermediate CAS 1770840-43-1 4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine COVID-19
Remdesivir ya Ugavi wa Kibiashara wa Watengenezaji na Wapatanishi Husika na Ubora wa Juu
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilyl Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir Metabolite (GS-441524) CAS 1191237-69-0
Remdesivir N-2 CAS ya Kati 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Jina la Kemikali | 4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine |
Visawe | 7-Iodopyrrolo[2,1-f][1,2,4]triazin-4-amine;Remdesivir-004;Uchafu wa Remdesivir 30 |
Nambari ya CAS | 1770840-43-1 |
Nambari ya CAT | RF-PI304 |
Hali ya Hisa | Katika Hisa, Uzalishaji Unaongezeka Hadi Mamia ya Kilo |
Mfumo wa Masi | C6H5IN4 |
Uzito wa Masi | 260.04 |
Chapa | Ruifu Chemical |
Kipengee | Vipimo |
Mwonekano | Poda ya Manjano Isiyokolea hadi Hudhurungi |
Spectrum ya Infrared | Inalingana na Muundo |
Usafi | ≥98.0% (HPLC) |
Kupoteza kwa Kukausha | ≤0.50% |
Uchafu Mmoja | ≤0.50% |
Vyuma Vizito | ≤20ppm |
Kiwango cha Mtihani | Kiwango cha Biashara |
Matumizi | Remdesivir ya kati (CAS 1809249-37-3) |
Kifurushi: Chupa, mfuko wa karatasi ya Alumini, ngoma ya Cardboard, 25kg/Ngoma, au kulingana na mahitaji ya mteja.
Hali ya Uhifadhi:Hifadhi kwenye vyombo vilivyofungwa mahali pa baridi na kavu;Kinga dhidi ya mwanga, unyevu na kushambuliwa na wadudu.
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine (CAS 1770840-43-1) ni ya Kati ya Remdesivir (CAS 1809249-37-3).Remdesivir ni kiwanja cha kuzuia virusi kinachotumiwa kuzuia kitendo cha RNA polymerase.Remdesivir awali ilichunguzwa kama tiba ya virusi vya Ebola, lakini ina uwezo wa kutibu aina mbalimbali za virusi vya RNA.Shughuli yake dhidi ya familia ya virusi vya coronavirus (CoV) kama vile SARS-CoV na MERS-CoV, ilielezewa mnamo 2017, na pia inachunguzwa kama matibabu inayoweza kutibu maambukizo ya SARS-CoV-2.